Witch Doctors And Stents (BSX)(JNJ)
No matter how many studies the medical community does, it cannot come up with a solid opinion for or against drug coated stents. The New England Journal of Medicine is out with the latest…
No matter how many studies the medical community does, it cannot come up with a solid opinion for or against drug coated stents. The New England Journal of Medicine is out with the latest…
From BioHealth Investor Biotechnology ONYX PHARM INC +96.98% LPATH INC +16.67% CYTORI THERAPEUTICS +11.42% VION PHARM INC +10.88% CARDIOVASCULAR BIOTH +9.80% Diagnostic Substances ADEZA BIOMEDICAL COR +53.12% OSTEOLOGIX INC +7.62% IMMUCELL CP +5.77% COLEY…
by Robert S. Dailey Aventis Pharma v. Amphastar Pharms., No. 03-cv-887 (C.D. Cal. 2007) In a ruling issued last Friday, Judge Mariana R. Pfaelzer of the U.S. District Court for the Central District of…
Onyx Pharmaceuticals (ONXX-NASDAQ) is probably as happy as you could imagine that it partnered with Bayer (BAY-NYSE/ADR). ONXX shares are up 60% after they announced that an independent data monitoring committee has reviewed the…
by H.S. AyoubBioHealth Investor.com It was in 1796 that Edward Jenner successfully immunized a child against smallpox, and his experiment introduced the word ‘vaccination’. This event motivated a tremendous movement by doctors all over…
Thermogenesis Corp (KOOL), a developer of cord blood collection and processing units, released subpar fiscal second quarter results on Friday. While earnings increased by 19%, net profit dropped by more than $250,000. Although on…
by JMHOBioTechnology Stock Blog Gilead (GILD) is a large biotech company with a portfolio of marketed products that include royalties from the blockbuster Tamiflu for treatment and prevention of influenza, as well as HIV…
From BioHealth Investor Biotechnology REXAHN PHARMACEUTICL +18.18% LPATH INC +14.29% NEURALSTEM INC +8.60% CELL GENESYS INC +7.85% ORTHOLOGIC CP +7.64% Diagnostic Substances SCOLR PHARMA INC +5.71% AVIGEN INC +4.58% THRESHOLD PHARMACEUT +4.40% SONUS PHARM…
From BioHealth Investor Biotechnology AURIGA LABORATORIES +22.32% ACCENTIA BIOPHARMACE +12.09% XENOPORT +11.09% CADENCE PHARM. INC. +10.07% BIODELIVERY SCI INTL +8.59% Diagnostic Substances ICAGEN, INC. +15.00% ISTA PHARMACTLS +14.15% GENE LOGIC INC +5.36% GENELABS TECH…
From BioHealth Investor Biotechnology DYAX CORP +9.51% FERMAVIR PHARMACEUTL +8.57% ZIOPHARM ONCOLOGY IN +7.30% ALNYLAM PHARMACEUT +6.75% GENITOPE CORPORATION +5.85% Diagnostic Substances EPICEPT CORPORATION +11.76% GENELABS TECH INC +5.00% DIGENE CP +4.09% MONOGRAM BIOSCIENCES…
by H.S. AyoubBioHealth Investor.com Due to federal budget constraints some 3000 patients could possibly be prevented from taking part in cancer trials nationwide, according to Robert L. Comis, president of the Coalition of Cancer…
One strategy that I like to follow when looking at smaller capped stocks is to keep an eye on company insiders, especially those whose investing history is almost perfect. One such investor is Phillip…
Cramer interviewed the CEO (Robert Hugin) of Celgene (CELG-NASDAQ), one name he has been very positive on before. Cramer said many on the street think they are a one-trick pony with Revlimid, but the…
3SBio Inc. (SSRX-NASDAQ) opened at a premium to its pricing out of the chute today. The company priced 7.7 million ADR shares at $16.00, and the first print was $17.50. The original range was…
From BioHealth Investor Biotechnology XOMA LTD +11.15% DYADIC INTERNATIONAL +9.27% ADVENTRX PHARMACTL +6.01% VION PHARM INC +5.63% GENVEC INC +5.61% Diagnostic Substances NYMOX PHARM CORP +15.67% EPICEPT CORPORATION +9.29% THRESHOLD PHARMACEUT +3.15% ABAXIS INC…